Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.

Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells. Clin Cancer Res. 2014 Mar 01; 20(5):1355-65.

View in: PubMed

subject areas

Adult
Aged
Antigens, Neoplasm
Cancer Vaccines
Carboxymethylcellulose Sodium
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunization
Immunotherapy, Adoptive
Male
Middle Aged
Multiple Myeloma
Neoplasm Proteins
Poly I-C
Polylysine
T-Lymphocytes
Transplantation, Autologous
Treatment Outcome